Business News

Weight loss drugs could be a gamechanger for women with...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a st...

International inbound travel to U.S. shows mixed recovery

Canadian travel dropped sharply in the first half of 2025, according to numbers ...

Insurers just marked the costliest first half of the ye...

Global insured losses for the first half of this year have reached $84 billion, ...

Rich American Express customers continue to spend freel...

American Express said Friday that travel spending in the quarter was weaker than...

Sarepta shares plunge 40% as future of its gene therapy...

Sarepta reported a third death tied to its gene therapies.

Sarepta shares plunge 30% as future of its gene therapy...

Sarepta reported a third death tied to its gene therapies.

Why Delta and United are pulling away from the airline ...

U.S. airlines are struggling from weaker domestic spring and summer demand and l...

As streaming services chase profitability, kids’ conten...

Kids' programming like "CoComelon" and "Bluey" is becoming an important tool in ...

How family offices can protect the bottom line when put...

Sargento heir Joshua Gentine told CNBC how to set the next generation up for suc...

Netflix posts earnings beat as revenue grows 16% in sec...

Netflix reports second-quarter earnings after the closing bell Thursday.

Netflix earnings are out – here are the numbers

Netflix reports second-quarter earnings after the closing bell Thursday.

Here's where Walmart prices are changing — and staying ...

Price increases on things like baby gear and home goods at Walmart reflect broad...

Banks are thriving so far in Trump’s economy. Here's wh...

Banks are giving the all-clear signal on the U.S. economy during the turbulent o...

Netflix earnings are after the bell. Here's what to expect

Netflix reports second-quarter earnings after the closing bell Thursday.

Homebuilders are slashing prices at the highest rate in...

More homebuilders are cutting prices as interest rates remain stubbornly high, a...

Bristol Myers Squibb, Pfizer to sell blockbuster blood ...

The companies' new effort would bypass traditional middlemen to cut the drug's m...